Evaluating electroacupuncture for treating acute ankle sprains

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study compares the effectiveness of electroacupuncture combined with surrounding acupuncture against sham electroacupuncture and traditional ice compress treatment for acute lateral ankle sprains. It aims to assess the safety and efficacy of the acupuncture methods using musculoskeletal ultrasound techniques. The research will also explore the physiological and biochemical changes in the affected areas and optimize treatment parameters to enhance therapeutic outcomes. The goal is to integrate traditional Chinese medicine with Western practices in orthopedics.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Meets the diagnostic criteria for a grade I or II injury;
* Onset time≤48h;
* The patient aged between18 and 60, gender is not limited;
* The skin of the ankle joint on the affected side is intact, without breakage or ulceration;

Exclusion Criteria:

* Combined with ankle fracture;
* Grade III injury or complete ligament rupture;
* Those who cannot comply with the treatment program. Those with keloid, localized combination of other skin diseases, and those who are not suitable for electroacupuncture treatment;
* Those with serious cardiovascular, cerebrovascular, hepatic, renal, hematopoietic system or systemic failure, connective tissue disease, hemophilia, diabetes mellitus, malignant tumors, and those who are prone to bleeding tendency.

Where it's running

• The Third Affiliated Hospital of Zhejiang Chinese Medical University
  Hangzhou, Zhejiang, China Recruiting

Study contacts

• Study coordinator: Qimiao Hu, Phd
• Email: huqimiao315@126.com
• Phone: +86 151 5817 5001

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Electroacupuncture plus PD‑1 immunotherapy for advanced non‑small cell lung cancer with ECOG 2

  This trial will see if adding electroacupuncture to PD‑1 immunotherapy helps people with advanced non‑small cell lung cancer who have an ECOG performance status of 2.

  Recruiting First Teaching Hospital of Tianjin University of Traditional Chinese Medicine · Tianjin, Tianjin Municipality · NCT07239661

• Electroacupuncture plus PD-1 immunotherapy for older adults with advanced non-small cell lung cancer

  It will test whether adding electroacupuncture to PD‑1 immunotherapy helps people aged 65 and older with advanced non‑small cell lung cancer live longer, feel better, or have fewer side effects.

  Recruiting First Teaching Hospital of Tianjin University of Traditional Chinese Medicine · Tianjin, Tianjin Municipality · NCT07086300

• Zusanli (ST36) electroacupuncture plus immunotherapy in NSCLC before surgery

  This trial tests whether adding electroacupuncture at ST36 to standard neoadjuvant immunotherapy helps patients with NSCLC better respond to treatment.

  Recruiting West China Hospital · Chengdu, Sichuan · NCT07076836

• Electroacupuncture plus immunotherapy after surgery for early non-small cell lung cancer

  This trial tests whether adding electroacupuncture (and in some groups a Zilongjin herbal tablet) to immune checkpoint inhibitor treatment after surgery helps people with stage II–III non‑small cell lung cancer reduce recurrence and live longer.

  Recruiting Phase 2/3 First Teaching Hospital of Tianjin University of Traditional Chinese Medicine · Tianjin · NCT07034326

• Electroacupuncture to prevent menstrual-related migraine

  This trial tests whether electroacupuncture, compared with sham electroacupuncture, can prevent migraines that occur around a woman’s period.

  Recruiting Guang'anmen Hospital of China Academy of Chinese Medical Sciences · Beijing, Beijing Municipality · NCT07023926

• Electroacupuncture to reduce chemo-related nausea and other gut symptoms in breast cancer

  This trial will test whether adding electroacupuncture to standard anti-nausea medications helps reduce nausea, vomiting, poor appetite, and dry mouth in breast cancer patients receiving highly emetogenic chemotherapy.

  Recruiting Phase 3 Affiliated Hospital of Qinghai University · Xining, Qinghai · NCT06952920

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.